Financing was led by Redmile Group and other existing investors, according to a news release. The money will support commercialization of the Evoke closed-loop spinal cord stimulator.
Saluda’s Evoke system is the first designed to sense and measure neural responses and automatically adjust therapy.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.